Literature DB >> 18751693

Increasing the cell viability and heterologous protein expression of Pichia pastoris mutant deficient in PMR1 gene by culture condition optimization.

Hong Liang Zhao1, Chong Xue, Yang Wang, Xue Qin Yao, Zhi Min Liu.   

Abstract

In this study, we assessed the potential of PMR1-disrupted Pichia pastoris (Pppmr1) expressing human serum albumin and interferon alpha 2b fusion protein (HSA-IFN-alpha 2b) in large-scale fermentation. The high osmotic pressure of standard basal salts medium (BSM) was detrimental to the growth and viability of Pppmr1. HSA-IFN-alpha 2b was secreted into a supernatant with a concentration of up to 112 mg/L after 20 h of induction and then began to decline. In vitro stability tests indicated that the disappearance of HSA-IFN-alpha 2b was ascribed to proteolytic degradation. Decreasing the salt concentration of BSM medium to one quarter of the original formula improved the growth and viability of Pppmr1. As a result of reduced cell lysis and protease release, HSA-IFN-alpha 2b was stable in the supernatant, which enabled a longer production phase (30 h) and a higher expression level (215 mg/L). Lowering the culture temperature to 20 degrees C increased the cell viability during carbon source transition and alleviated the oxygen and methanol limitation, which extended the production phase to 40 h and increased the expression level to 680 mg/L. The addition of 2% Soytone prolonged the production phase to 60 h and increased the expression level to 1,260 mg/L, which was more than tenfold higher than that of Pppmr1 cultured under the conditions recommended by Invitrogen.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751693     DOI: 10.1007/s00253-008-1666-0

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  8 in total

1.  Gene and protein sequence optimization for high-level production of fully active and aglycosylated lysostaphin in Pichia pastoris.

Authors:  Hongliang Zhao; Kristina Blazanovic; Yoonjoo Choi; Chris Bailey-Kellogg; Karl E Griswold
Journal:  Appl Environ Microbiol       Date:  2014-02-21       Impact factor: 4.792

2.  Effects of Temperature and pH on Recombinant Thaumatin II Production by Pichia pastoris.

Authors:  Jewel Ann Joseph; Simen Akkermans; Jan F M Van Impe
Journal:  Foods       Date:  2022-05-16

3.  Optimization of production of the anti-keratin 8 single-chain Fv TS1-218 in Pichia pastoris using design of experiments.

Authors:  Rozbeh Jafari; Birgitta E Sundström; Patrik Holm
Journal:  Microb Cell Fact       Date:  2011-05-16       Impact factor: 5.328

4.  Characterization and immunological activity of different forms of recombinant secreted Hc of botulinum neurotoxin serotype B products expressed in yeast.

Authors:  Bo Liu; DanYang Shi; ShaoHong Chang; Xin Gong; YunZhou Yu; ZhiWei Sun; Jun Wu
Journal:  Sci Rep       Date:  2015-01-08       Impact factor: 4.379

5.  Green Process: Improved Semi-Continuous Fermentation of Pichia pastoris Based on the Principle of Vitality Cell Separation.

Authors:  Denggang Wang; Wenjie Li; Xinying Zhang; Shuli Liang; Ying Lin
Journal:  Front Bioeng Biotechnol       Date:  2021-11-30

6.  Investigating the physiological response of Pichia (Komagataella) pastoris GS115 to the heterologous expression of misfolded proteins using chemostat cultures.

Authors:  Andrew R Hesketh; Juan I Castrillo; Trevor Sawyer; David B Archer; Stephen G Oliver
Journal:  Appl Microbiol Biotechnol       Date:  2013-09-11       Impact factor: 4.813

Review 7.  Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production.

Authors:  Mudassar Ahmad; Melanie Hirz; Harald Pichler; Helmut Schwab
Journal:  Appl Microbiol Biotechnol       Date:  2014-04-18       Impact factor: 4.813

8.  Global transcriptome profiling reveals genes responding to overproduction of a small secretory, a high cysteine- and a high glycosylation-bearing protein in Yarrowia lipolytica.

Authors:  Paulina Korpys-Woźniak; Ewelina Celińska
Journal:  Biotechnol Rep (Amst)       Date:  2021-06-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.